Search

Maria Marvich

Examiner (ID: 9363)

Most Active Art Unit
1633
Art Unit(s)
1633, 1634, 1631, 1636
Total Applications
1459
Issued Applications
618
Pending Applications
253
Abandoned Applications
627

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 73233 [patent_doc_number] => 07749493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Chimeric adenoviruses' [patent_app_type] => utility [patent_app_number] => 11/207626 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 10 [patent_no_of_words] => 21424 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749493.pdf [firstpage_image] =>[orig_patent_app_number] => 11207626 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/207626
Chimeric adenoviruses Aug 17, 2005 Issued
Array ( [id] => 8527663 [patent_doc_number] => 08304233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same' [patent_app_type] => utility [patent_app_number] => 11/198885 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 29 [patent_no_of_words] => 98577 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11198885 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198885
Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same Aug 3, 2005 Issued
Array ( [id] => 9239034 [patent_doc_number] => 08603824 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Process for improved protein expression by strain engineering' [patent_app_type] => utility [patent_app_number] => 11/189375 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 36952 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 733 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11189375 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/189375
Process for improved protein expression by strain engineering Jul 25, 2005 Issued
Array ( [id] => 5767433 [patent_doc_number] => 20060019237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'In vitro wound healing assay and device' [patent_app_type] => utility [patent_app_number] => 11/185434 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9027 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019237.pdf [firstpage_image] =>[orig_patent_app_number] => 11185434 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/185434
In vitro wound healing assay and device Jul 18, 2005 Abandoned
Array ( [id] => 576125 [patent_doc_number] => 07459546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase regulatory sequences for gene expression in oleaginous yeast' [patent_app_type] => utility [patent_app_number] => 11/183664 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 27828 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459546.pdf [firstpage_image] =>[orig_patent_app_number] => 11183664 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/183664
Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase regulatory sequences for gene expression in oleaginous yeast Jul 17, 2005 Issued
Array ( [id] => 4824866 [patent_doc_number] => 20080124308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins' [patent_app_type] => utility [patent_app_number] => 11/632302 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11862 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124308.pdf [firstpage_image] =>[orig_patent_app_number] => 11632302 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/632302
Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins Jul 13, 2005 Abandoned
Array ( [id] => 5767604 [patent_doc_number] => 20060019292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same' [patent_app_type] => utility [patent_app_number] => 11/181148 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19453 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019292.pdf [firstpage_image] =>[orig_patent_app_number] => 11181148 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/181148
Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same Jul 12, 2005 Abandoned
Array ( [id] => 5141306 [patent_doc_number] => 20070003522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Methods and compositions for improved retroviral gene and drug delivery' [patent_app_type] => utility [patent_app_number] => 11/175401 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27843 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003522.pdf [firstpage_image] =>[orig_patent_app_number] => 11175401 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/175401
Methods and compositions for improved retroviral gene and drug delivery Jul 6, 2005 Abandoned
Array ( [id] => 5894913 [patent_doc_number] => 20060003452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Vector packaging cell line' [patent_app_type] => utility [patent_app_number] => 11/172147 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003452.pdf [firstpage_image] =>[orig_patent_app_number] => 11172147 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/172147
Vector packaging cell line Jun 29, 2005 Abandoned
Array ( [id] => 5826914 [patent_doc_number] => 20060062772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Polypeptide delivery system' [patent_app_type] => utility [patent_app_number] => 11/166340 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4713 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062772.pdf [firstpage_image] =>[orig_patent_app_number] => 11166340 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/166340
Polypeptide delivery system Jun 26, 2005 Abandoned
Array ( [id] => 7772955 [patent_doc_number] => 08119119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Non-integrative and non-replicative lentivirus, preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/628534 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9353 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119119.pdf [firstpage_image] =>[orig_patent_app_number] => 11628534 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/628534
Non-integrative and non-replicative lentivirus, preparation and uses thereof Jun 23, 2005 Issued
Array ( [id] => 5894357 [patent_doc_number] => 20060002896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Method of generating recombinant MVA' [patent_app_type] => utility [patent_app_number] => 11/149793 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7904 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002896.pdf [firstpage_image] =>[orig_patent_app_number] => 11149793 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/149793
Method of generating recombinant MVA Jun 9, 2005 Abandoned
Array ( [id] => 73232 [patent_doc_number] => 07749492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'AAV vectors and methods' [patent_app_type] => utility [patent_app_number] => 11/145035 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13367 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749492.pdf [firstpage_image] =>[orig_patent_app_number] => 11145035 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/145035
AAV vectors and methods Jun 2, 2005 Issued
Array ( [id] => 6966003 [patent_doc_number] => 20050232900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Serotype of adenovirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/140418 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 41134 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232900.pdf [firstpage_image] =>[orig_patent_app_number] => 11140418 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/140418
Serotype of adenovirus and uses thereof May 26, 2005 Abandoned
Array ( [id] => 5343257 [patent_doc_number] => 20090181907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter' [patent_app_type] => utility [patent_app_number] => 11/569625 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8124 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181907.pdf [firstpage_image] =>[orig_patent_app_number] => 11569625 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569625
Drug comprising as the active ingredient proliferative vector containing survivin promoter May 22, 2005 Issued
Array ( [id] => 7020055 [patent_doc_number] => 20050222074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Modulators of bone homeostasis identified in a high-throughput screen' [patent_app_type] => utility [patent_app_number] => 11/133849 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 32670 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222074.pdf [firstpage_image] =>[orig_patent_app_number] => 11133849 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/133849
Modulators of bone homeostasis identified in a high-throughput screen May 19, 2005 Abandoned
Array ( [id] => 4486423 [patent_doc_number] => 07884085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes' [patent_app_type] => utility [patent_app_number] => 11/127360 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 3721 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884085.pdf [firstpage_image] =>[orig_patent_app_number] => 11127360 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/127360
Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes May 11, 2005 Issued
Array ( [id] => 352790 [patent_doc_number] => 07491812 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-02-17 [patent_title] => 'Copper-inducible promoter system' [patent_app_type] => utility [patent_app_number] => 11/120009 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1481 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491812.pdf [firstpage_image] =>[orig_patent_app_number] => 11120009 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/120009
Copper-inducible promoter system May 1, 2005 Issued
Array ( [id] => 4771926 [patent_doc_number] => 20080057584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Intervention In The Energy Metabolism Of Eukaryote Cells For The Purposes Of Selection And Increased Expression' [patent_app_type] => utility [patent_app_number] => 11/578567 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8425 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057584.pdf [firstpage_image] =>[orig_patent_app_number] => 11578567 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/578567
Intervention In The Energy Metabolism Of Eukaryote Cells For The Purposes Of Selection And Increased Expression Apr 14, 2005 Abandoned
Array ( [id] => 4563447 [patent_doc_number] => 07846687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Cytomegalovirus Intron A fragments' [patent_app_type] => utility [patent_app_number] => 11/103805 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 13366 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846687.pdf [firstpage_image] =>[orig_patent_app_number] => 11103805 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/103805
Cytomegalovirus Intron A fragments Apr 10, 2005 Issued
Menu